Matches in Nanopublications for { ?s ?p "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.
- assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP597439.RAAJumsEhad0-FomxKrbSrTrPk9jXZqvLe3mxLGtBQcb4130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597439.RAAJumsEhad0-FomxKrbSrTrPk9jXZqvLe3mxLGtBQcb4130_provenance.
- NP597446.RARGboclZeMDl12vpzXwa2ve4GLL0245LICPUGG7yA0e4130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597446.RARGboclZeMDl12vpzXwa2ve4GLL0245LICPUGG7yA0e4130_provenance.
- NP597437.RA7EMwIRqw3TTOYNmlMeCP9SdV7ey_o1ybsHgnNDWP_9E130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597437.RA7EMwIRqw3TTOYNmlMeCP9SdV7ey_o1ybsHgnNDWP_9E130_provenance.
- NP597440.RA3zjMN2QFKKX4JtNMX2o-oCJhfM5I7sivRJIb-lT_ygc130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597440.RA3zjMN2QFKKX4JtNMX2o-oCJhfM5I7sivRJIb-lT_ygc130_provenance.